Terms: = Leukemia AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB
18 results:
1. An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant.
Mende H; Khatri A; Lange C; Poveda-Cuevas SA; Tascher G; Covarrubias-Pinto A; Löhr F; Koschade SE; Dikic I; Münch C; Bremm A; Brunetti L; Brandts CH; Uckelmann H; Dötsch V; Rogov VV; Bhaskara RM; Müller S
Cell Rep; 2023 Dec; 42(12):113484. PubMed ID: 37999976
[TBL] [Abstract] [Full Text] [Related]
2. The presence of blastocyst within the uteri facilitates lumenal epithelium transformation for implantation via upregulating lysosome proteostasis activity.
Wang P; Du S; Guo C; Ni Z; Huang Z; Deng N; Bao H; Deng W; Lu J; Kong S; Zhang H; Wang H
Autophagy; 2024 Jan; 20(1):58-75. PubMed ID: 37584546
[TBL] [Abstract] [Full Text] [Related]
3. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
Ding Y; Chen J; Li S; Wren JD; Bajpai AK; Wang J; Tanaka T; Rice HC; Hays FA; Lu L; Zhang XA
Oncogene; 2023 Mar; 42(12):861-868. PubMed ID: 36788350
[TBL] [Abstract] [Full Text] [Related]
4. MAP kinase-dependent autophagy controls phorbol myristate acetate-induced macrophage differentiation of HL-60 leukemia cells.
Mandic M; Misirkic Marjanovic M; Vucicevic L; Jovanovic M; Bosnjak M; Perovic V; Ristic B; Ciric D; Harhaji-Trajkovic L; Trajkovic V
Life Sci; 2022 May; 297():120481. PubMed ID: 35304128
[TBL] [Abstract] [Full Text] [Related]
5. Homocysteine Suppresses Autophagy Through AMPK-mTOR-tfeb Signaling in Human THP-1 Macrophages.
Yang YP; Ren YG; Cai BQ; Huang DD
J Cardiovasc Pharmacol; 2022 May; 79(5):730-738. PubMed ID: 35121714
[TBL] [Abstract] [Full Text] [Related]
6. GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
Salles DC; Asrani K; Woo J; Vidotto T; Liu HB; Vidal I; Matoso A; Netto GJ; Argani P; Lotan TL
J Pathol; 2022 Jun; 257(2):158-171. PubMed ID: 35072947
[TBL] [Abstract] [Full Text] [Related]
7. A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.
Zeng Y; Zhang X; Lin D; Feng X; Liu Y; Fang Z; Zhang W; Chen Y; Zhao M; Wu J; Jiang L
J Hematol Oncol; 2021 Nov; 14(1):189. PubMed ID: 34749790
[TBL] [Abstract] [Full Text] [Related]
8. tfeb links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia.
Yun S; Vincelette ND; Yu X; Watson GW; Fernandez MR; Yang C; Hitosugi T; Cheng CH; Freischel AR; Zhang L; Li W; Hou H; Schaub FX; Vedder AR; Cen L; McGraw KL; Moon J; Murphy DJ; Ballabio A; Kaufmann SH; Berglund AE; Cleveland JL
Blood Cancer Discov; 2021 Mar; 2(2):162-185. PubMed ID: 33860275
[TBL] [Abstract] [Full Text] [Related]
9. Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy.
Humbert M; Seiler K; Mosimann S; Rentsch V; Sharma K; Pandey AV; McKenna SL; Tschan MP
Cell Death Differ; 2021 Aug; 28(8):2465-2481. PubMed ID: 33742137
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
Robichaud S; Fairman G; Vijithakumar V; Mak E; Cook DP; Pelletier AR; Huard S; Vanderhyden BC; Figeys D; Lavallée-Adam M; Baetz K; Ouimet M
Autophagy; 2021 Nov; 17(11):3671-3689. PubMed ID: 33590792
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors.
Sivakumaren SC; Shim H; Zhang T; Ferguson FM; Lundquist MR; Browne CM; Seo HS; Paddock MN; Manz TD; Jiang B; Hao MF; Krishnan P; Wang DG; Yang TJ; Kwiatkowski NP; Ficarro SB; Cunningham JM; Marto JA; Dhe-Paganon S; Cantley LC; Gray NS
Cell Chem Biol; 2020 May; 27(5):525-537.e6. PubMed ID: 32130941
[TBL] [Abstract] [Full Text] [Related]
12. All-trans retinoic acid (ATRA)-induced tfeb expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
[TBL] [Abstract] [Full Text] [Related]
13. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
[TBL] [Abstract] [Full Text] [Related]
14. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
[TBL] [Abstract] [Full Text] [Related]
15. Impairment of autophagy: from hereditary disorder to drug intoxication.
Aki T; Funakoshi T; Unuma K; Uemura K
Toxicology; 2013 Sep; 311(3):205-15. PubMed ID: 23851159
[TBL] [Abstract] [Full Text] [Related]
16. Genomic heterogeneity of translocation renal cell carcinoma.
Malouf GG; Monzon FA; Couturier J; Molinié V; Escudier B; Camparo P; Su X; Yao H; Tamboli P; Lopez-Terrada D; Picken M; Garcia M; Multani AS; Pathak S; Wood CG; Tannir NM
Clin Cancer Res; 2013 Sep; 19(17):4673-84. PubMed ID: 23817689
[TBL] [Abstract] [Full Text] [Related]
17. Translocation carcinomas of the kidney after chemotherapy in childhood.
Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
[TBL] [Abstract] [Full Text] [Related]
18. Renal carcinoma-associated transcription factors TFE3 and tfeb are leukemia inhibitory factor-responsive transcription activators of E-cadherin.
Huan C; Sashital D; Hailemariam T; Kelly ML; Roman CA
J Biol Chem; 2005 Aug; 280(34):30225-35. PubMed ID: 15994295
[TBL] [Abstract] [Full Text] [Related]
